Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Incurable Cancers”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05057247
What this trial is testing

Duvelisib Plus Docetaxel In Recurrent/Metastatic HNSCC

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck (SCCHN)Recurrent Squamous Cell Carcinoma of the Head and NeckMetastatic Head and Neck Cancer+2 more
Glenn J. Hanna 26
Early research (Phase 1)UnknownNCT06054932
What this trial is testing

Safety, Tolerability, and Immunogenicity of LK101 Alone in Participants With Incurable Solid Tumors

Who this might be right for
Advanced Solid Tumor
Beijing Likang Life Science and Tech Co., Ltd. 18
Early research (Phase 1)Study completedNCT00390117
What this trial is testing

AT7519M in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
LymphomaUnspecified Adult Solid Tumor, Protocol Specific
NCIC Clinical Trials Group 34
Not applicableLooking for participantsNCT04406662
What this trial is testing

Routine Evaluation of People Living With Cancer

Who this might be right for
Cachexia; CancerAdvanced CancerQuality of Life
University of Edinburgh 600
Early research (Phase 1)Study completedNCT04147247
What this trial is testing

A Trial to Find the Safe Dose for BI 905681 in Patients With Incurable Tumours or Tumours That Have Spread

Who this might be right for
Neoplasms
Boehringer Ingelheim 21
Not applicableStudy completedNCT02650583
What this trial is testing

Enhancing Connections Program in Improving Communication Between Patients With Incurable Cancer and Their Children

Who this might be right for
Advanced Malignant Neoplasm
University of Washington 41
Testing effectiveness (Phase 2)UnknownNCT02071069
What this trial is testing

Efficacy and Tolerance of Maintenance Therapy in Patients With Incurable Advanced Colorectal Cancer

Who this might be right for
Incurable Colorectal CancerRAS-wild-type
Tianshu Liu 54
Not applicableStudy completedNCT03669497
What this trial is testing

Hypo-Fractionated Radiotherapy in Breast Cancer

Who this might be right for
Breast CancerAdvanced Breast CancerMetastatic Breast Cancer
Tata Medical Center 33
Not applicableEnded earlyNCT01902966
What this trial is testing

Feasibility - Beta Adrenergic Blockade (BB) in Cervical Cancer (CX)

Who this might be right for
Cervical Cancer
M.D. Anderson Cancer Center 6
Early research (Phase 1)Ended earlyNCT03166631
What this trial is testing

A Trial to Find the Safe Dose for BI 891065 Alone and in Combination With BI 754091 in Patients With Incurable Tumours or Tumours That Have Spread

Who this might be right for
NeoplasmsNeoplasm MetastasisCarcinoma, Non-Small-Cell Lung
Boehringer Ingelheim 62
Early research (Phase 1)Study completedNCT00648102
What this trial is testing

Phase I Study of CDX-1307, hCG-B Vaccine, for Patients With Incurable, Locally Advanced or Metastatic Breast, Colorectal, Pancreatic, Bladder or Ovarian Cancer

Who this might be right for
Breast CancerColorectal CancerPancreatic Cancer+2 more
Celldex Therapeutics 36
Not applicableStudy completedNCT03237884
What this trial is testing

Romanian-Swiss Research Programme IZERZO

Who this might be right for
Advanced Incurable Cancer
Cantonal Hospital of St. Gallen 308
Not applicableStudy completedNCT02534675
What this trial is testing

Study of Molecular Profile-Related Evidence to Determine Individualized Therapy for Advanced or Poor Prognosis Cancers

Who this might be right for
Cancer
University of California, San Diego 506
Early research (Phase 1)Study completedNCT01525602
What this trial is testing

Safety Study of PLX3397 and Paclitaxel in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumors
Daiichi Sankyo 74
Early research (Phase 1)Active Not RecruitingNCT02537418
What this trial is testing

Durvalumab With or Without Tremelimumab in Advanced Incurable Solid Malignancies Given With or Without Standard Chemotherapy Regimens

Who this might be right for
Solid Malignancies
Canadian Cancer Trials Group 153
Early research (Phase 1)Study completedNCT00676910
What this trial is testing

A Research Study of JNJ-26854165 to Determine the Safety and Dose in Patients With Advanced Stage or Refractory Solid Tumors.

Who this might be right for
Neoplasms
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 71
Early research (Phase 1)Study completedNCT00107250
What this trial is testing

AZD2171 + Chemotherapy in Advanced NSCLC, Colorectal Cancer, or Other Cancer Suitable for Treatment With Capecitabine (Non-Small Lung Cancer Patients Closed to Enrollment as 8/9/07)

Who this might be right for
Colorectal CancerLung CancerUnspecified Adult Solid Tumor, Protocol Specific
NCIC Clinical Trials Group 50
Large-scale testing (Phase 3)Study completedNCT02394795
What this trial is testing

Panitumumab and RAS, Diagnostically-useful Gene Mutation for mCRC

Who this might be right for
Colorectal Cancer
Takeda 823
Early research (Phase 1)Study completedNCT01065025
What this trial is testing

Open Label, Dose Escalation Trial of Oral Eg5 Kinesin-spindle Inhibitor 4SC-205 in Patients With Advanced Malignancies

Who this might be right for
Advanced and Incurable Solid TumorsMalignant Lymphomas
4SC AG 60
Early research (Phase 1)Active Not RecruitingNCT04958239
What this trial is testing

Test BI 765179 Alone and in Combination With Ezabenlimab in Patients With Advanced Cancer (Solid Tumors) and BI 765179 in Combination With Pembrolizumab in Patients With Advanced Head and Neck Cancer

Who this might be right for
Neoplasms
Boehringer Ingelheim 151
Next Page